Home/ Supplements/ Kava/ Hawaiian Kava 520 mg

Hawaiian Kava 520 mg

product on market Capsule Maui Medicinal Safety: 60/100
60/100

Review before taking

  • dried Kava root powder: 520mg is 2.1× the Tolerable Upper Intake Level (250mg)
  • 100% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Dried kava root powder is supported by moderate evidence for reducing symptoms of anxiety. However, the low safety score reflects potential concerns regarding hepatotoxicity and liver health. Due to limited evidence coverage, the overall efficacy of this specific formulation remains understudied.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

dried Kava root powder: 520mg is 2.1× the Tolerable Upper Intake Level (250mg)

AI-generated · Qwen 3.6 · grounded in 2 sources · methodology

This product received a low safety score because it contains more than twice the recommended daily upper limit of dried Kava root powder.

Label

Product Label

Label for Hawaiian Kava 520 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
60
Servings
Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Exceeds UL by 2.1× (UL: 250 mg) 15 studies (A:0, B:5)

Other Ingredients

Vegetable Capsules
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Suggested Use: As herbal nutrient support take 1 capsule once daily, or as directed.

Warnings & Precautions

Keep out of reach of children

Formulation Notes

520 mg per cap

Gluten free GMO free

Vegan

Additional Information

800.936.6532

Metadata

Product Details

UPC / SKU6 73125 11145 8
DSLD Entry Date2020-10-23
Product TypeBotanical
FormCapsule
DSLD ID235704
Data Updated2026-04-11
Research

Research Evidence

19
Research Sources
48
Avg Quality
8
Rct
5
Systematic Review
4
Meta Analysis
2
Clinical Trial
B Kava extract for treating anxiety
Meta Analysis The Cochrane database of systematic reviews 2003 PubMed
B Kava for Generalized Anxiety Disorder: A Review of Current Evidence
Meta Analysis Journal of alternative and complementary medicine (New York, N.Y.) 2018 PubMed DOI
B Kava extract for treating anxiety
Systematic Review The Cochrane database of systematic reviews 2001 PubMed
B Kava extract for treating anxiety
Systematic Review The Cochrane database of systematic reviews 2002 PubMed
B The effectiveness and safety of Kava Kava for treating anxiety symptoms: A systematic review and analysis of randomized clinical trials
Systematic Review Complementary therapies in clinical practice 2018 PubMed DOI
C Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study
Rct The Australian and New Zealand journal of psychiatry 2020 PubMed DOI
C Kava and St. John's Wort: current evidence for use in mood and anxiety disorders
Systematic Review Journal of alternative and complementary medicine (New York, N.Y.) 2009 PubMed DOI
C Neuroimaging Insights: Kava's (Piper methysticum) Effect on Dorsal Anterior Cingulate Cortex GABA in Generalized Anxiety Disorder.
Rct Nutrients PubMed DOI
C The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava
Meta Analysis Annals of internal medicine 2002 PubMed
C Efficacy of kava extract for treating anxiety: systematic review and meta-analysis
Meta Analysis Journal of clinical psychopharmacology 2000 PubMed
View all evidence for Kava →
Compare

Similar Products

View all Kava products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.